Skip to search formSkip to main contentSkip to account menu

Stage 3 lower case b

Known as: stage 3b, stage iiib 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2019
Highly Cited
2019
Talimogene laherparepvec (T‐VEC) is a modified herpes simplex virus, type 1 (HSV‐1), which can be administered intralesionally in… 
Review
2018
Review
2018
Five-year survival rates for non–small cell lung cancer (NSCLC) range from 14% to 49% for stage I to stage IIIA disease, and are… 
Highly Cited
2009
Highly Cited
2009
BACKGROUND Vascularized iliac bone-grafting has been reported to be successful for patients with osteonecrosis of the femoral… 
2007
2007
BackgroundThe aim of the present study was to identify the clinicopathological factors affecting locoregional recurrence (LRR) in… 
Highly Cited
2004
Highly Cited
2004
PURPOSE To improve treatment outcome for patients presenting with inflammatory breast cancer (IBC), we have sequentially… 
Highly Cited
2002
Highly Cited
2002
PURPOSE To define clinical and pathologic predictors of local-regional recurrence (LRR) for patients treated with neoadjuvant… 
Highly Cited
1999
Highly Cited
1999
PURPOSE In a previous phase I study cisplatin (CDDP), gemcitabine (GEM), and vinorelbine (VNR) combination therapy was safe and… 
1998
1998
Highly Cited
1997
Highly Cited
1997
This study was performed to determine whether pleural effusion in patients with advanced non-small cell lung cancer (NSCLC) has a…